Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

about

Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Item

http://www.wikidata.org/entity/Q37182939

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Debio 0507 primarily forms diaminocyclohexane-Pt-d

@nl

Debio 0507 primarily forms dia ...... ) DNA adducts in HCT116 cells.

@en

type

Item

label

Debio 0507 primarily forms diaminocyclohexane-Pt-d

@nl

Debio 0507 primarily forms dia ...... ) DNA adducts in HCT116 cells.

@en

prefLabel

Debio 0507 primarily forms diaminocyclohexane-Pt-d

@nl

Debio 0507 primarily forms dia ...... ) DNA adducts in HCT116 cells.

@en

P1476

Debio 0507 primarily forms dia ...... ) DNA adducts in HCT116 cells.

@en

P2093

C L King

http://www.w3.org/2001/XMLSchema#string

J A Swenberg

http://www.w3.org/2001/XMLSchema#string

K E DeKrafft

http://www.w3.org/2001/XMLSchema#string

L Cicurel

http://www.w3.org/2001/XMLSchema#string

L Collins

http://www.w3.org/2001/XMLSchema#string

M Barbier

http://www.w3.org/2001/XMLSchema#string

S G Chaney

http://www.w3.org/2001/XMLSchema#string

P2860

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins

2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex

Oxaliplatin: a review of evolving concepts.

Towards biomarker-dependent individualized chemotherapy: exploring cell-specific differences in oxaliplatin-DNA adduct distribution using accelerator mass spectrometry.

Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.

Displacement of the bidentate malonate ligand from (d,l-trans-1,2-diaminocyclohexane)malonatoplatinum(II) by physiologically important compounds in vitro.

Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.

LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.

P2888

s00280-011-1744-3

P304

665-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-011-1744-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Srinivas Ramachandran

Wenbin Lin

P577

2011-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21968950

http://www.w3.org/2001/XMLSchema#string

P932

3777240

http://www.w3.org/2001/XMLSchema#string